About Pmv Pharmaceuticals (PMVP)
PMV Pharmaceuticals, Inc. is a precision oncology company, which is engaged in the discovery and development of small molecule, tumor-agnostic therapies targeting p53. The Company’s lead product candidate, PC14586, is an orally available small molecu... Read more
- 10.11
- 10.28
- 9.50
- 25.10
- -15.2%
- --
- 830.48k
- 558.97k
- 468M
- 8.99
- -57.3%
- %
Stock News
21 minutes ago
WEX launches Driver App in Australia to help SMBs save money on fuel
Yahoo
27 minutes ago
TSA data shows Sunday was busiest air travel day since December 2019
Yahoo
31 minutes ago
Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting
Yahoo
31 minutes ago
PRA Group Announces Refinancing of European Revolving Credit Facility
Yahoo
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
